Please provide your email address to receive an email when new articles are posted on . The study, which was presented at the virtual PCR e-Course and simultaneously published in Circulation, also ...
Nov. 14, 2005 — The U.S. Food and Drug Administration (FDA) has approved a real-time cardiopulmonary resuscitation monitoring and feedback device to assist responders in providing appropriate ...
Please provide your email address to receive an email when new articles are posted on . Antiplatelet therapy with aspirin and clopidogrel has been the cornerstone of medical therapy for acute coronary ...
The relationship of platelet responsiveness to antiplatelet medications; and, the correlation of poor response, and overall platelet aggregation while on dual antiplatelet therapy to the risk of ...
Tirofiban is far superior to cangrelor at achieving rapid and potent inhibition of platelet aggregation in patients undergoing primary percutaneous coronary intervention for ST-elevation MI. And ...
Two 'snapshots' of a receptor that are of critical importance for blood coagulation has been captured by an international team of researchers. The scientists now hope to be able to develop novel drugs ...
Cigarette smoking appears to augment the antiplatelet effect of clopidogrel but not prasugrel, according to a study of patients with stable coronary artery disease (CAD) published online April 24, ...
SAN FRANCISCO, CA—Patients with acute coronary syndrome on maintenance dose prasugrel had a reduction in high on-treatment platelet reactivity rates after a prasugrel reload strategy, according to a ...
SAN DIEGO--(BUSINESS WIRE)--CeleCor Therapeutics, Inc. announced positive data from the company’s completed phase 1 clinical study of RUC-4 which was published in the Journal of the American Heart ...
SAN DIEGO--(BUSINESS WIRE)--CeleCor Therapeutics, Inc. today announced preliminary positive results in the company’s ongoing phase 1 clinical study with RUC-4, a novel subcutaneous platelet GPIIb/IIIa ...
An international team of researchers in cooperation with the University of Bonn has taken two "snapshots" of a receptor which are of critical importance for blood coagulation. The scientists now hope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results